Anti-tumoral capabilities of effector cells after IFN-α or CpG-motif treatment of cocultured dendritic cells

被引:14
|
作者
Erhardt, Michael [1 ]
Schmidt-Wolf, Ingo G. H. [1 ]
Sievers, Elisabeth [1 ]
Frank, Susanne [1 ]
Strehl, John [1 ]
von Lilienfeld-Toal, Marie [1 ]
Gorschlueter, Marcus [1 ]
机构
[1] Univ Bonn, Dept Internal Med 1, D-53105 Bonn, Germany
关键词
dendritic cells; CIK cells; LAK cells; interferon-alpha; interleukin-4; CpG-ODN;
D O I
10.1007/s00005-006-0048-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Ex vivo expansion of monocyte-derived dendritic cells (mDCs) and subsequent coculture with autologous cytokine-induced killer (CIK) cells is an established system to create specific and non-specific anti-tumoral immunity. mDCs constitute the most frequently applied DC subset in clinical studies. One recently published approach to optimize the immunological functions of the DC/CIK cell system is the replacement of interleukin (IL)-4 by interferon (IFN)-alpha in the maturation process of the DCs. Materials and Methods: The expressions of relevant surface antigens of IL-4-DCs and IFN alpha-DCs by flow cytometry and the anti-tumoral activation of effector cells cocultured with both types of DCs using cytotoxicity assays were compared. In addition, short-term coculture experiments with both types of DCs and IFN gamma-LAK effector cells were performed and compared with standard CIK cell coculture experiments. Results: Regarding the expressions of functionally relevant surface markers, no differences could be detected for CD80, CD83, and HLA-DR between IFN alpha-DCs and IL-4-DCs, whereas the mean fluorescence intensities of CD40, CD86, CD54, and HLA-ABC were decreased and the expression of CD14 was increased for IFN alpha-DCs. Moreover, no enhancement of cytotoxicity of cocultured CIK cells against tumor cell lines (A498 and SW480) was detected by the use of IFN alpha-DCs. Additionally, coculture experiments with IFN gamma-LAK cells were performed and unexpectedly higher lysis rates in comparison with the established IL-4-DC/CIK coculture model was observed. Early incubation of the mDCs with several CpG-ODNs failed to increase the anti-tumoral cytotoxicity of the cocultured IFN gamma-LAK cells. Conclusions: These results demonstrate that in the mDC/CIK cell system, IFN alpha-DCs are not superior in inducing anti-tumoral cytotoxicity and even moderately inferior regarding the expression of functionally relevant surface markers compared with IL-4-DCs.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 50 条
  • [31] IL12-secreting dendritic cells are required for optimal activation of human secondary lymphoid tissue T-cells: Implication for anti-tumoral vaccination protocols.
    Rouard, H
    Marquet, J
    Leon, A
    Haioun, C
    Copie-Bergman, C
    Plonquet, A
    Farcet, JP
    Delfau-Larue, MH
    BLOOD, 2001, 98 (11) : 39B - 39B
  • [32] Immunomodulatory effects of the liver:: Deletion of activated CD4+ effector cells and suppression of IFN-γ-producing cells after intravenous protein immunization
    Klugewitz, K
    Blumentahl-Barby, F
    Schrage, A
    Knolle, PA
    Hamann, A
    Crispe, IN
    JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2407 - 2413
  • [33] Antigen-specific effector CD8 T cells regulate allergic responses via IFN-γ and dendritic cell function
    Tang, Yafang
    Guan, Shou Ping
    Chua, Benson Y. L.
    Zhou, Qian
    Ho, Adrian W. S.
    Wong, Kenneth H. S.
    Wong, Kok Loon
    Wong, W. S. Fred
    Kemeny, David M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (06) : 1611 - +
  • [34] ANTI-TUMORAL EFFECT OF THYMOSIN PREINCUBATED SYNGENEIC BONE-MARROW CELLS AND SPLENOCYTES - A MODEL APPLICABLE TO CANCER-TREATMENT
    CUPISSOL, D
    GOLDSTEIN, AL
    SERROU, B
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 153 - 153
  • [35] Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy
    Masurier, C
    Pioche-Durieu, P
    Colombo, BM
    Lacave, R
    Lemoine, FM
    Klatzmann, D
    Guigon, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1998, : 25 - 25
  • [36] A cycle involving HMGB1, IFN-γ and dendritic cells plays a putative role in anti-tumor immunity
    Gao, Qun
    Li, Feng
    Wang, Shumin
    Shen, Zhibo
    Chen, Shaoyan
    Ping, Yu
    Qin, Guohui
    Chen, Xinfeng
    Yang, Li
    Cao, Ling
    Liu, Shasha
    Zhang, Bin
    Wang, Liping
    Sun, Yan
    Zhang, Yi
    CELLULAR IMMUNOLOGY, 2019, 343
  • [37] In vitro induction of specific anti-tumoral immunity against laryngeal carcinoma by using human interleukin-12 gene-transfected dendritic cells
    Liang Wen
    Wang Xue-feng
    CHINESE MEDICAL JOURNAL, 2011, 124 (09) : 1357 - 1361
  • [38] CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-γ-secreting Simian immunodeficiency virus-specific T cells
    Teleshova, N
    Kenney, J
    Jones, J
    Marshall, J
    Van Nest, G
    Dufour, J
    Bohm, R
    Lifson, JA
    Gettie, A
    Pope, M
    JOURNAL OF IMMUNOLOGY, 2004, 173 (03): : 1647 - 1657
  • [39] The pancreatic tumor microenvironment of treatment-naïve patients causes a functional shift in γδ T cells, impairing their anti-tumoral defense
    Lo Presti, Elena
    Cupaioli, Francesca
    Scimeca, Daniela
    Unti, Elettra
    Di Martino, Vincenzo
    Daidone, Rossella
    Amata, Michele
    Scibetta, Nunzia
    Soucie, Erinn
    Meraviglia, Serena
    Iovanna, Juan
    Dusetti, Nelson
    De Gaetano, Andrea
    Merelli, Ivan
    Di Mitri, Roberto
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [40] Plasmacytoid dendritic cells in multiple sclerosis: Loss of IFN-alpha production after treatment with IFN-beta
    Balashov, KE
    Dembinsky-Vaknin, A
    Santos, L
    Weiner, HL
    NEUROLOGY, 2006, 66 (05) : 312 - 312